medicines


'New trade policy for America'
The agreement announced today is a fundamental shift in US trade policy and clears the way for broad, bipartisan congressional support for the Peru and Panama FTAs.
US action plan must be opposed, groups tell govt
Thai Aids activists and academics called on the Commerce Ministry yesterday to reject the "action plan" proposed by the United States to remove Thailand from its priority watch list for intellectual property protection.
FTA: The unstated reason for the watch list
The US decision to put Thailand on its "priority watch list" this month was prompted by failed talks on a free trade agreement, as well as the patent-busting of US-made pharmaceuticals, a former US trade official said Friday.
Drug firms against trade changes
US drugmakers, among the biggest proponents of free-trade agreements, are now lobbying to stop Democrats and the Bush administration from reworking pending trade deals to curb provisions that benefit the industry.
Drug makers fear trade deal from House Dems, administration
Research-based pharmaceutical companies could be among the biggest losers if House Democrats and the Bush administration reach an agreement on trade, industry sources said this week.
Drug dispute could lead to trade trouble
The Thai government's showdown with multinational drug companies over compulsory licensing could result in a downgrade on Washington's watch list of countries with poor intellectual property (IP) rights protection, trade sources say.
Intellectual property, bilateral agreements and sustainable development: A strategy note
This paper addresses the main threats of the intellectual property chapters in the bilateral and regional agreements with the US for access to medicines, give an overview of the reactions from different sectors to these agreements, and outline some strategic considerations for future action.
FTA: Malaysia imposes terms on data exclusivity for US pharmaceuticals
Malaysia has set some conditions in agreeing to the U.S. request for data exclusivity (DE) for new pharmaceutical products in the bilateral free trade agreement (FTA) negotiations, Health Minister Datuk Seri Dr Chua Soi Lek said today.
Trade pact risks environment, public health
For the past few years, the backers and denouncers of a free trade accord between Korea and the United States have feuded like the Montagues and Capulets. Not surprisingly, the two camps are still polarized on whether the trade pact bringing together the world's largest and 10th largest economies is destined to be a happy marriage or Shakespearean tragedy.